In an analysis of patients on hemodialysis in New York City, there were substantial racial/ethnic disparities in COVID-19 rates that were not explained by neighborhood social vulnerability. The findings appear in an upcoming ...
Jun 4, 2021
0
1
Patients with chronic kidney disease and Type 2 diabetes who took the experimental drug finerenone were about 30% less likely to develop the heart rhythm disorder atrial fibrillation (AFib) than those taking a placebo, according ...
May 17, 2021
0
2
Dapagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, did not significantly reduce the risk of organ failure or death or improve recovery in patients hospitalized with COVID-19 who are at high risk of developing ...
May 17, 2021
0
3
A research group from Kumamoto University, Japan has discovered that cysteinylated albumin (oxidized albumin) in serum can be used as an early diagnostic marker for diabetic kidney disease. Compared with urinary albumin, ...
May 17, 2021
0
8
Chronic kidney disease affects the lives of millions of people. It's a condition marked by the loss of several key kidney functions such as removing toxins from the blood. To compensate for this loss, a patient can undergo ...
May 12, 2021
0
3
An ongoing debate is focused on race-based algorithms in medicine—such as an adjustment for Black race in equations that estimate individuals' kidney function. A study appearing in an upcoming issue of JASN examines the ...
May 6, 2021
0
5
(HealthDay)—Farxiga (dapagliflozin) oral tablets are now approved for adults with chronic kidney disease at risk for disease progression, the U.S. Food and Drug Administration announced Friday.
May 4, 2021
0
9
(HealthDay)—COVID-19 infection is associated with significant mean QTc prolongation at days 2 and 5 of hospitalization, according to a study published online April 23 in JAMA Network Open.
Apr 28, 2021
0
0
Nephronophthisis (NPH) is a kidney disease affecting mainly children. Now, for the first time, researchers at Tokyo Medical and Dental University (TMDU) have studied a number of adults with NPH and highlighted clinical, genetic ...
Apr 23, 2021
0
6
A new study from researchers at the Perelman School of Medicine at the University of Pennsylvania found significant disparities in the use of sodium-glucose cotransporter 2 (SGLT2) inhibitors, a class of drugs proven to treat ...
Apr 15, 2021
0
5
